# Antagonist-Elicited Cannabis Withdrawal

> **NCT01041170** · PHASE1 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)**

## Conditions studied

- Cannabis
- Dependence

## Interventions

- **DRUG:** THC
- **DRUG:** Rimonobant
- **DRUG:** Rimonabant

## Key facts

- **NCT ID:** NCT01041170
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04-16
- **Primary completion:** 2010-01-11
- **Final completion:** 2010-01-11
- **Target enrollment:** — (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01041170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01041170, "Antagonist-Elicited Cannabis Withdrawal". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01041170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*